نتائج البحث 1471-1480 من 5003 لعملية البحث عن Blood factor II
In particular, we plan to bank blood and bone marrow from patients with newly diagnoses or relapsed acute leukemia (AML or ALL) for future biological studies.
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...
Rochester, Minn. The purpose of this study is to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with ...
The purpose of this study is to look at the blood's clotting response in people who have suffered a traumatic injury and compare it with non-injured people.
... two lines of therapy as measured by objective ... Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection.
... factors for outcomes ... Molecular Analysis of Blood for the Detection of Cardiovascular Pathogens ... توجّه للصفحة 22 · توجّه للصفحة 33 · توجّه للصفحة 44 ...
The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...
s, Pulmonary embolism, Factor V Leiden ... blood clotting disorder. إظهار المزيد من مجالات ... II M.D.. Minnesota. Misra, Sanjay M.D.. Minnesota ...
ry embolism, Factor V Leiden, Vasospastic ... blood clotting disorder. إظهار المزيد من مجالات ... 2 laser treatment, ...Phonosurgery, Velopharyngeal ...
... Blood Flow and Elasticity with Contrast-Enhanced ... In the phase II part, to evaluate the preliminary antitumor activity of two ... Blood Flow and ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.